fbpx

Be Medispa Brings Groundbreaking Restylane Eyelight Treatment to Lexington, Kentucky

LEXINGTON, KY – July 24 , 2023 – Be Medispa, Kentucky’s premier medical spa, is happy to be among the first in the United States to offer the innovative Restylane Eyelight treatment. This state-of-the-art, non-invasive solution designed to revitalize tired-looking eyes is now available to our distinguished patients, emphasizing Be Medispa’s dedication to providing advanced aesthetic solutions.

“Our mission has always been to bring the most advanced, effective, and safe aesthetic treatments to our patients,” says Chasity Hester, PA-C. “With the introduction of Restylane Eyelight, we’re offering a scientifically backed, trusted solution that has proven to deliver visible, long-lasting results.”

The treatment targets and treats volume loss in the tear trough area, often the root cause of tired-looking eyes. The non-surgical procedure uses a trusted hyaluronic acid-based filler to add volume to the under-eye site, helping to reduce the appearance of dark under-eye shadows and hollows and brighten the eyes. The result is a well-rested, rejuvenated look.

As a testament to the effectiveness of Restylane Eyelight, recent clinical studies show that 83% of women between the ages of 23 and 68 reported being satisfied or extremely satisfied with their treatment. In comparison, 82.9% noticed a significant improvement even 6.5 months post-treatment. Furthermore, 94.3% would recommend the treatment to a friend. This is a quick treatment and patients can return to their daily activities immediately afterward.

Founded in 2004, Be Medispa has consistently remained at the forefront of aesthetic treatments, offering a personalized, comprehensive approach to skincare and wellness. Recognized for their excellence, the qualified team at Be Medispa continues to impact Lexington, Kentucky’s beauty and wellness landscape significantly.

To schedule an appointment, call our office at 859-266-5483 or schedule online here.



© All Rights Reserved, Company BeMedispa 2024